StockData
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp (BGLC) stock

BGLCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3090% below fair value
$0.77−0.05 (-6.56%)

Close on Nov 17, 2026Market cap $2.25MP/E –Yield –

BioNexus Gene Lab revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BioNexus Gene Lab's revenue for the twelve months ending Jun 30, 2026 was $3.13M, down 67.3% year over year. For fiscal 2025 it was $7.42M, down 21.9% from the year before. The highest annual figure on record is $13.36M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.42M-21.9%
FY2024Dec 31, 2024$9.51M-2.7%
FY2023Dec 31, 2023$9.77M-10.6%
FY2022Dec 31, 2022$10.93M-18.2%
FY2021Dec 31, 2021$13.36M+17.3%
FY2020Dec 31, 2020$11.39M+8872.0%
FY2019Dec 31, 2019$126.96K-40.2%
FY2018Dec 31, 2018$212.33K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$76.16K-96.6%
Q1 FY2026Mar 31, 2026$22.84K-98.9%
Q4 FY2025Dec 31, 2025$483.76K-80.8%
Q3 FY2025Sep 30, 2025$2.54M-3.3%
Q2 FY2025Jun 30, 2025$2.26M+14.5%
Q1 FY2025Mar 31, 2025$2.14M-10.3%
Q4 FY2024Dec 31, 2024$2.52M+11.0%
Q3 FY2024Sep 30, 2024$2.63M+3.0%
Q2 FY2024Jun 30, 2024$1.97M-23.1%
Q1 FY2024Mar 31, 2024$2.38M+0.2%
Q4 FY2023Dec 31, 2023$2.27M-20.0%
Q3 FY2023Sep 30, 2023$2.55M-0.8%
Q2 FY2023Jun 30, 2023$2.57M+3.3%
Q1 FY2023Mar 31, 2023$2.38M-21.5%
Q4 FY2022Dec 31, 2022$2.84M-12.5%
Q3 FY2022Sep 30, 2022$2.58M-28.0%
Q2 FY2022Jun 30, 2022$2.49M-19.6%
Q1 FY2022Mar 31, 2022$3.03M-12.2%
Q4 FY2021Dec 31, 2021$3.25M-21.3%
Q3 FY2021Sep 30, 2021$3.58M+15.7%
Q2 FY2021Jun 30, 2021$3.09M+180.2%
Q1 FY2021Mar 31, 2021$3.45M+12.3%
Q4 FY2020Dec 31, 2020$4.13M+7677.5%
Q3 FY2020Sep 30, 2020$3.09M+12687.0%
Q2 FY2020Jun 30, 2020$1.10M+4998.2%
Q1 FY2020Mar 31, 2020$3.07M+10830.0%
Q4 FY2019Dec 31, 2019$53.05K+463.9%
Q3 FY2019Sep 30, 2019$24.17K-73.6%
Q2 FY2019Jun 30, 2019$21.65K-80.6%
Q1 FY2019Mar 31, 2019$28.09K–
Q4 FY2018Dec 31, 2018$9.41K–
Q3 FY2018Sep 30, 2018$91.63K–
Q2 FY2018Jun 30, 2018$111.30K–

More BioNexus Gene Lab figures

See a number that looks wrong?